EXCEL - Experiential Cases for Empagliflozin & Linagliptin

Type 2 Diabetes patients with previous CV events have multiple CV risk factors and microvascular complications. Listen to experts how a novel combination of SGLT2i and DPP-4i has early durable benefits to reach the glycemic goal with cardiovascular renal protection from experts.

Middle-aged man with microvascular complications and suboptimal glycemic control with a need to reduce the hypoglycemia risk presents in the clinic.  This Podcast highlights how the individualized therapy with a safe and effective combination of antidiabetic drugs led to optimization of diabetes management and improvement in the quality of life.

50 years old obese T2D female patient on metformin therapy, with 9% HbA1c, has microalbuminuria and a family history of heart disease. What would have been the next step when the patient presented with inadequately controlled in this case study? Listen to experts.

A 52-year-old female patient with multiple metabolic defects remains uncontrolled in the glycemic profile. What would have been the next step when the patient presented with inadequately controlled in this case study? Listen to experts.

A 58-year-old patient with short duration of T2DM, obese with obstructive sleep apnea, and multiple CV risk factors presents with uncontrolled hyperglycemia. What are the primary factors you would like to consider providing the comprehensive care to this patient? Listen to experts.

Ms. Agarwal, 52 years diabetic overweight hypertensive female presented in the emergency department with acute ST elevated MI & uncontrolled Diabetes, what are the factors we need to consider while individualizing the therapy in such patients? Listen to experts.

A middle-aged corporate executive with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the experts while he discusses the important aspects to assess and manage such patients.